Comprehensive multi-omics analysis reveals prognostic, immune, and therapeutic signatures of TNFAIP family genes in breast cancer
PLOS One · 2026
DOI: 10.1371/journal.pone.0349012 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Tahereh Barati und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Tumor necrosis factor-alpha-induced proteins (TNFAIPs) are key regulators of inflammation, apoptosis, and immune signaling, yet their integrated roles in breast cancer (BC) remain poorly characterized. While individual TNFAIP members have been studied in other cancers, a comprehensive multi-omics characterization of this gene family in BC is still needed.
Methods
We performed an integrative bioinformatics analysis using public datasets (UALCAN, TIMER, bc-GenExMiner, cBioPortal, STRING, GeneMANIA, Enrichr, MethSurv, GDSC, CTRP, and HPA) to evaluate TNFAIP family members in BC. Expression, genomic alterations, methylation patterns, immune infiltration, and drug sensitivity were analyzed across clinical and molecular subtypes. Where applicable, multiple hypothesis testing was controlled using the Benjamini–Hochberg false discovery rate (FDR) method.
Results
Among TNFAIPs, TNFAIP6 and EFNA1 were significantly upregulated in BC, while TNFAIP1, TNFAIP2, TNFAIP3, PTX3, TNFAIP8, and STEAP4 were downregulated. Elevated TNFAIP2, TNFAIP3, and TNFAIP8 expression correlated with improved overall survival (OS). Multi-database integration revealed that TNFAIP3 expression was strongly correlated with infiltration of CD4 ⁺ T cells, dendritic cells, and neutrophils. Functional enrichment highlighted the NF-κB, PI3K-Akt, and TNF signaling pathways as key regulatory axes. Drug-sensitivity analyses indicated subtype-dependent responses linked to TNFAIP dysregulation.
Conclusion
This study provides a comprehensive multi-omics characterization of TNFAIP family genes in BC, addressing the role of inflammatory signaling in tumor progression and identifying potential biomarkers and therapeutic targets. These findings enhance the understanding of TNFAIP-mediated molecular networks and offer a resource for translational and experimental research in BC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Genetics and Molecular Medicine, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
- Department of Molecular Medicine, Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
- Institute of Biology, Leiden University, Leiden, Netherland.
- Systems Biotechnology Department, National Institute for Genetic Engineering and Biotechnology, Tehran, Iran.
ORCID-Profile: Fatemeh Mokhles, Golsa Nayeb Ghanbar Hosseini, Najaf Allahyari Fard
Zitieren
APA
Barati, T., Moghaddam, M. M., Mokhles, F., Mirzaei, Z., Ebrahimi, A., Hosseini, G. N. G., & Allahyari Fard, N. (2026). Comprehensive multi-omics analysis reveals prognostic, immune, and therapeutic signatures of TNFAIP family genes in breast cancer. PLOS One. https://doi.org/10.1371/journal.pone.0349012
Vancouver
Barati T, Moghaddam MM, Mokhles F, Mirzaei Z, Ebrahimi A, Hosseini GNG, et al. Comprehensive multi-omics analysis reveals prognostic, immune, and therapeutic signatures of TNFAIP family genes in breast cancer. PLOS One. 2026. doi:10.1371/journal.pone.0349012
BibTeX
@article{Barati2026,
author = {Barati, Tahereh and Moghaddam, Madiheh Mazaheri and Mokhles, Fatemeh and Mirzaei, Zohreh and Ebrahimi, Amir and Hosseini, Golsa Nayeb Ghanbar and Allahyari Fard, Najaf},
title = {Comprehensive multi-omics analysis reveals prognostic, immune, and therapeutic signatures of TNFAIP family genes in breast cancer},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0349012}
}
EUVIMED